Synapse - Stephen Nimer

Results (19)

Host acid sphingomyelinase regulates microvascular function not tumor immunity

Meeting Abstract

Garcia-Barros, M.; Lacorazza, H. D.; Petrie, H.; Haimovitz-Friedman, A.; Cordon-Cardo, C.; Nimer, S.; Fuks, Z.; Kolesnick, R. N.
Cancer Research (2005)

Fulltext@MSK | Save

Identification of a MEF gene mutation in a familial hemophagocytic lymphohistiocytosis patient that decreases MEF transcriptional activity

Meeting Abstract

Lacorazza, H. D.; LoPiccolo, S.; Rubenstein, E.; Liu, Y.; Nunes, J.; Hasle, H.; Fadeel, B.; Ericson, K.; Henter, J. I.; Nimer, S. D.
Blood (2005)

Fulltext@MSK | Save

Id1 regulates the choice of hematopoietic stem cells to self-renew or commit to differentiation

Meeting Abstract

Jankovic, V.; Ciarrocchi, A.; Boccuni, P.; Benezra, R.; Nimer, S. D.
Blood (2005)

Fulltext@MSK | Save

Second-line therapy with ICE followed by high dose therapy and autologous stem cell transplantation for relapsed/refractory peripheral T-Cell lymphomas: Minimal benefit when analyzed by intent to treat

Meeting Abstract

Horwitz, S.; Moskowitz, C.; Kewalramani, T.; Hamlin, P.; Straus, D.; O'connor, O.; Noy, A.; Portlock, C.; Nimer, S.; Palomba, M. L.; more...
Blood (2005)

Fulltext@MSK | Save

The serum free light chain ratio after one or two cycles of treatment is highly predictive of the magnitude of final response in patients undergoing initial treatment for multiple myeloma

Meeting Abstract

Hassoun, H.; Reich, L.; Klimek, V. M.; Dhodapkar, M.; Cohen, A.; Kewalramani, T.; Riedel, E. R.; Hedvat, C. V.; Teruya-Feldstein, J.; Filippa, D. A.; more...
Blood (2005)

Fulltext@MSK | Save

Plasma cell gene-expression profiles in patients with systemic AL amyloidosis: Responses to melphalan and stem cell transplant are associated with differential expression of genes involved in translation, protein degradation and detoxification

Meeting Abstract

Comenzo, R. L.; Zhou, P.; Wang, L. M.; Nimer, S. D.; Olshen, A. B.
Blood (2005)

Fulltext@MSK | Save

Risk-adapted dosing of melphalan for systemic AL amyloidosis (AL) lowers treatment-related mortality: Early death but not post-3 month survival is linked to cardiac involvement

Meeting Abstract

Comenzo, R. L.; Zhou, P.; Hassoun, H.; Kewalramani, T.; Klimek, V.; Cohen, A. D.; Ferrand, S. K.; Dhodapkar, M.; Feldstein, J. T.; Fleisher, M.; more...
Blood (2005)

Fulltext@MSK | Save

Adjuvant dexamethasone (D)+/- thalidomide (T) improves hematologic and organ responses after risk-adapted high-dose melphalan with autologous stem cell transplant (SCT) for patients with systemic AL amyloidosis (AL)

Meeting Abstract

Cohen, A. D.; Zhou, P.; Reich, L.; Hassoun, H.; Teruya-Feldstein, J.; Filippa, D. A.; Fleisher, M.; Nimer, S. D.; Comenzo, R. L.
Blood (2005)

Fulltext@MSK | Save

Induction of remission prior to transplantation improves the disease-free survival (DFS) of patients with advanced myelodysplastic syndromes (MDS) treated with myeloablative T-cell depleted (TCD) stem cell transplants (SCT) from HLA identical siblings